Medpace Holdings, Inc. Stockholders Equity

Quick Answer

Medpace Holdings, Inc. reported Stockholders Equity of $459.07 million for fiscal year 2025.

Medpace Holdings, Inc. Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2025 $459.07M -44.4%
2024 $825.54M +47.7%
2023 $558.95M +44.7%
2022 $386.39M -59.5%
2021 $952.93M +18.3%
2020 $805.78M +10.9%
2019 $726.28M +21.3%
2018 $598.86M +17.6%
2017 $509.26M -16.6%
2016 $610.71M +47.7%
2015 $413.47M +2.9%
2014 $401.97M -2.9%
2014 $414.00M

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
September 30, 2025 $293.64M -66.7% +70.4%
June 30, 2025 $172.35M -77.4% -71.0%
March 31, 2025 $593.61M -11.6% -28.1%
December 31, 2024 $825.54M +47.7% -6.3%
September 30, 2024 $881.44M +87.2% +15.4%
June 30, 2024 $763.60M +95.3% +13.7%
March 31, 2024 $671.54M +93.4% +20.1%
December 31, 2023 $558.95M +44.7% +18.7%
  • Medpace Holdings, Inc. showed a decrease of -44.4% in Stockholders Equity compared to the prior fiscal year.
  • Over the 2014–2025 period, Medpace Holdings, Inc.’s stockholders equity has grown by 10.9% (from $414.00 million to $459.07 million).
  • The most recent figure is from Medpace Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 10, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment